SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-10-044769
Filing Date
2010-08-16
Accepted
2010-08-16 16:59:05
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 v194003_10q.htm 10-Q 487452
2 v194003_ex31-1.htm EX-31.1 17021
3 v194003_ex31-2.htm EX-31.2 17151
4 v194003_ex32-1.htm EX-32.1 6911
5 v194003_ex32-2.htm EX-32.2 7057
  Complete submission text file 0001144204-10-044769.txt   537131
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53127 | Film No.: 101020660
SIC: 4731 Arrangement of Transportation of Freight & Cargo